Figure 2.
Figure 2. Overall survival by chemotherapy subtype in the IELSG study of 426 patients with primary mediastinal large B-cell lymphoma (PMBL). Reprinted with permission from Zinani et al. Haematologica. 2002;87:1258–1264.

Overall survival by chemotherapy subtype in the IELSG study of 426 patients with primary mediastinal large B-cell lymphoma (PMBL). Reprinted with permission from

Zinani et al. Haematologica. 2002;87:1258–1264.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal